(secondQuint)Safety and Efficacy of Adding AZARGA Adjunctive to Prostaglandin Therapy.

 This study consisted of 3 study visits (Screening/Baseline, Week 4, and Week 12).

 Eligible patients self-administered the study medication (AZARGA(R) Eye Drops), adjunct to their current prostaglandin monotherapy for 3 months.

.

 Safety and Efficacy of Adding AZARGA Adjunctive to Prostaglandin Therapy@highlight

The purpose of this study was to evaluate the safety and efficacy of adding AZARGA(R) as a single agent to prostaglandin monotherapy in patients with either ocular hypertension or primary open-angle glaucoma.

